Bladder Cancer - Results from #320

Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy. June 15, 2023

Medicaid Expansion and Racial Disparity in Timely Multidisciplinary Treatment in Muscle Invasive Bladder Cancer. June 15, 2023

Treatment Patterns and Efficacy of Chemotherapy After Pembrolizumab in Advanced Urothelial Cancer-a Real-World Study in the pre-Antibody-Drug Conjugate Era. June 14, 2023

A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study. June 14, 2023

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives. June 13, 2023

Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review. June 13, 2023

Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence. June 12, 2023

Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites. June 12, 2023

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members. June 9, 2023

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. June 9, 2023

The role of radiation therapy for de novo metastatic bladder and renal cancers. June 9, 2023

Absence of detrusor muscle in TUR-BT specimen - can we predict who is at highest risk? June 9, 2023

Differential Expression of LncRNA in Bladder Cancer Development. June 9, 2023

Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective. June 8, 2023

The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study. June 8, 2023

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens. June 7, 2023

A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer. June 7, 2023

The Influence of Preoperative Hydronephrosis on the Prognosis after Radical Cystectomy among Patients with Different Pathological Stages of Bladder Cancer. June 6, 2023

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer. June 6, 2023

Sequential therapy of advanced bladder cancer after prior perioperative systemic treatment : Recommendations from the Interdisciplinary Bladder Carcinoma Working Group (IABC) of the DKG e. V.. June 5, 2023

Page 17 of 482